Diabetes that impacts on routine activities predicts slower recovery after total knee arthroplasty: an observational study  by Amusat, Nurudeen et al.
Journal of Physiotherapy 60 (2014) 217–223
J o u rn a l o f
PHYSIOTHERAPY
journal homepage: www.e lsev ier .com/ locate / jphysResearch
Diabetes that impacts on routine activities predicts slower recovery after total
knee arthroplasty: an observational study
Nurudeen Amusat a, Lauren Beaupre b,c, Gian S Jhangri d, Sheri L Pohar e,
Scot Simpson f, Sharon Warren a, C Allyson Jones b
a Faculty of Rehabilitation Medicine, University of Alberta; bDepartment of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta; cOrthopedic Research, Capital
Health; d School of Public Health, University of Alberta; eCanadian Agency for Drugs and Technologies in Health, Ottawa; f Faculty of Pharmacy and Pharmaceutical Sciences, University
of Alberta, Edmonton, CanadaK E Y W O R D S
Total knee arthroplasty
Diabetes
Pain
Function
Recovery
A B S T R A C T
Question: In the 6 months after total knee arthroplasty (TKA), what is the pattern of pain resolution and
functional recovery in people without diabetes, with diabetes that does not impact on routine activities,
andwith diabetes that does impact on routine activities? Is diabetes that impacts on routine activities an
independent predictor of slower resolution of pain and functional recovery after TKA? Design:
Community-based prospective observational study. Participants: A consecutive cohort of 405 people
undergoing primary TKA, of whom 60 (15%) had diabetes. Participants with diabetes were also asked
preoperatively whether diabetes impacted on their routine activities. Participants were categorised into
three groups: no diabetes (n = 345), diabetes with no impact on activities (n = 41), and diabetes that
impacted activities (n = 19). Outcome measures: Pain and function were measured using the Western
Ontario andMcMaster Universities (WOMAC) Osteoarthritis Index within the month before surgery and
1, 3 and 6 months after surgery. Demographic, medical and surgical factors were also measured, along
with depression, social support and health-related quality of life.Results:No baseline differences in pain
and function were seen among the three groups (p > 0.05). Adjusting for age, gender and contralateral
joint involvement across the 6 postoperative months, participants with diabetes that impacted on
routine activities had pain scores that were 8.3 points higher (indicating greater pain) and function
scores that were 5.4 points higher (indicating lower function) than participants without diabetes.
Participants with diabetes that doesn’t impact on routine activities had similar recovery to thosewithout
diabetes. Conclusion: People undergoing TKA who report preoperatively that diabetes impacts on their
routine activities have less recovery over 6 months than those without diabetes or those with diabetes
that does not impact on routine activities. Physiotherapists could institute closer monitoring within the
hospital and community settings for people undergoing TKAwho perceive that diabetes impacts on their
routine activities. [Amusat N, Beaupre L, Jhangri GS, Pohar SL, Simpson S, Warren S, Jones CA (2014)
Diabetes that impacts on routine activities predicts slower recovery after total knee arthroplasty:
an observational study. Journal of Physiotherapy 60: 217–223]
 2014 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Prevalence of arthritis among adults with diabetes is high, with
estimates of 48% and 52%.1,2 This is not unexpected, because both
arthritis and diabetes are more prevalent in older adults and have
common risk factors such as obesity and cardiovascular disease.
When conservative management is exhausted for arthritis, total
knee arthroplasty (TKA) is a successful elective surgery to alleviate
pain and improve function.3 Estimates of diabetes prevalence in
peopleundergoingTKA range from8 to12%,4,5 althoughmore recent
estimates are as high as 22%.6 The increased prevalence of diabetes
among people undergoing primary TKA is believed to be related to
increasing life expectancy, obesity and overall diabetes rates.6
Similar to other surgical procedures,7–9 people with diabetes
who undergo TKA are at a higher risk of surgical complications,
systemic complications, non-routine hospital discharges (eg,http://dx.doi.org/10.1016/j.jphys.2014.09.006
1836-9553/ 2014 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/3.0/).prolonged hospitalisation) and mortality, compared to those
without diabetes.4,5,10,11 Glycaemic control is a signiﬁcant factor
in the postoperative recovery phase of TKA. People whose diabetes
is not well controlled have higher odds of perioperative
complications and mortality than those with well-controlled
diabetes.5 Clinical outcomes such as the Knee Society score12
appear to be comparable over the long term, regardless of diabetes
status.13,14 Although pain relief and functional recovery are
primary clinical goals after TKA, few studies have examined the
impact of diabetes on pain and functional recovery after joint
arthroplasty.13,15 Measures of function in older adults are
predictive of health utilisation and mortality.16
Observational studies suggest that the greatest amount of pain
relief and functional improvement occurs within the ﬁrst
6 months,17–19 yet it is unclear whether the recovery pattern over
this time period is different for people who have diabetes. The.V. This is an open access article under the CC BY-NC-ND license (http://
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arthroplasty has traditionally been evaluated in terms of the
presence or absence of diabetes, not in terms of functional difﬁculty
that is associatedwith diabetes. Evidence in high-functioning, older
womensuggests that self-reporteddifﬁculty inperformingactivities
is a strong indicator of preclinical disability.20 Speciﬁcally, asking
people about their preclinical difﬁculty with functional activities
appears to be informative of forthcoming disability.
The primary aim of the present studywas to determinewhether
people with diabetes have different patterns of recovery for both
pain and function over 6 months after TKA than those without
diabetes. Better deﬁning the pre-surgical effect of diabetes on the
recovery of TKA will have direct clinical importance when
screening for surgical candidates and planning postoperative
management. From a rehabilitation perspective, diabetes was
deﬁned in terms of the impact that it has on function, because it
may provide a far richer depiction of the severity of the condition
on pain and functional outcomes for TKA. The a priori hypothesis
speciﬁed that participants with diabetes who identiﬁed prior to
surgery that diabetes affected their routine activities would have a
slower recovery after TKA than those without diabetes or with
diabetes that did not affect routine activities. Therefore, the
speciﬁc research questions for the present study were:1. In the 6 months after TKA, what is the pattern of pain relief and
functional recovery in people without diabetes, with diabetes
that does not impact on routine activities, andwith diabetes that
does impact on routine activities?2. Is diabetes that impacts on routine activities an independent
predictor of slower resolution of pain and functional recovery in
people undergoing TKA?
Method
Design
This community-based, prospective, observational study
recruited a consecutive cohort of participants who were undergo-
ing TKA within a Canadian health region.
Participants
The study included people who were scheduled for a primary
elective TKA at one of the three tertiary hospitals within the
health region (Edmonton, Alberta, Canada) if they were aged
40 years or older, residing within the health region, and able to
speak English. People were excluded if they had hemiarthroplas-
ties uni-compartmental revisions, or emergency arthroplasties.
No bilateral joint arthroplasties were performed in this cohort.
All patients were managed using the health region’s clinical
pathway for TKA to ensure standardised medical, pharmacological
and rehabilitative care during their hospital stay. All 29 orthopae-
dic surgeons who were practising at one of the three hospitals
within the health region gave permission for their patients to be
contacted for participation in the study.
After consent was obtained, participants were interviewed
during their preadmission clinic visit within the month prior to
surgery. Follow-up interviewswere completed at 1, 3 and 6months
after surgery. In-person interviews were completed at the pread-
mission clinic visit and the follow-up interviewswere conducted by
telephone. Home interviews were conducted for participants who
were unable to complete telephone interviews. A trained research
assistant,whowasanalliedhealthprofessionalnotdirectly involved
in the care of the participants, conducted the interviews. Chart
reviews using a standardised data-collection form were performed
after hospital discharge to obtain surgical and perioperative
information, including: type and number of in-hospital postopera-
tive complications; discharge status; length of stay; and medical
information including diabetes, height and weight.Outcome measures
The primary outcome measure was the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC), a self-
administered health questionnaire that is designed to measure
disability of the osteoarthritic knee.21 Participants were asked to
respond speciﬁcally about the knee that was being replaced. The
WOMAC index yields aggregate scores for joint-speciﬁc pain (ﬁve
items), stiffness (two items) and physical function (17 items). Each
item uses a 5-point Likert scale. The range of subscale scores
ranged from 0 to 100 points, with a score of 0 indicating no pain or
dysfunction. Because improvements of 23 points for joint pain and
19 points for joint function on the WOMAC index are typically
rated by people as somewhat better as opposed to equal,22 the
differences between groups were considered against this thresh-
old. The WOMAC index has been found to be valid, reliable, and
responsive in people with arthritis and after arthroplasty.21,23,24
Diabetes status was determined by self-report and/or medical
chart. Because one of the primary outcomes was functional status,
participants were asked to rate how much impact diabetes had on
performing their routine activities by using a 4-point Likert scale
(none, mild, moderate or severe). Participants were asked this at
baseline and at the three follow-up interviews. They were not
reminded of their ratings in prior interviews. Using their baseline
rating, participants were then classiﬁed into one of three groups:
no diabetes, diabetes with no functional impact, and diabetes with
functional impact.
Each participant’s overall health status was evaluated using the
Health Utilities Index Mark 3 (HUI3) – a generic, multi-attribute
utility measure of health-related quality of life. Because people
with diabetes have a substantial illness burden directly related the
disease itself, its treatment, complications and the comorbid
medical conditions that are prevalent in diabetes, a generic health
measure was used to capture overall health. The HUI3 includes
eight attributes of health-related quality of life, including: vision,
hearing, speech, ambulation, dexterity, emotion, cognition, and
pain.25,26 The overall score for the HUI3 was calculated using a
multi-attribute utility function, with scores ranging from –0.36 to
1.0. Negative scores are assigned to health states that are
considered to be worse than dead, a score of zero reﬂects the
health state dead and 1.0 reﬂects perfect health (full function on all
eight attributes of the HUI3). A difference of at least 0.03 was
considered to be a meaningful change for the HUI3. Construct
validity of the HUI3 in type-2 diabetes and in people with
osteoarthritis has been reported previously.27–29 The HUI3 is also
valid in people who need a total hip arthroplasty due to
osteoarthritis.29
The Centre for Epidemiologic Studies Depression Scale (CES-D)
was used to screen for depressive symptoms. The scale has
20 items and each item is scored on a 4-point ordinal level, which
generates a total score with a range from 0 to 60.30 The CES-D has
good internal consistency with an alpha of 0.85 in the general
population and has satisfactory test-retest reliability.31 Partici-
pants were categorised into two groups: 0 to 15 indicated absent
depressive symptoms, and 16 or higher indicated depressive
symptoms.30 Using this threshold had high sensitivity (100%) and
speciﬁcity (88%) for depression in the previous month in a
community-based sample of older adults between the ages of
55 and 85 years.32
To evaluate social support, participants completed the 19-item
Medical Outcomes Study Social Support Survey (MOS),33 which
includes items related to tangible support, affection, positive social
interaction, and emotional or informational support. The total
score is a weighted average of all items, rescaled to range from 0 to
100, with higher scores representing greater available social
support.
Comorbid conditions were identiﬁed from a list of predeﬁned
comorbid conditions obtained from the Charlson Comorbidity
Index34 and the Canadian National Population Health Survey.35 No
gold standard exists regarding the measurement of comorbidity.
Research 219Although hospital-based comorbidity measures perform better at
predicting variables of health service utilisation, self-reported
comorbid conditions is as useful whenmeasuring the impact of the
comorbidity on health-related quality of life.36 The speciﬁc
comorbidities were derived from self-report and/or admission
conditions listed in the hospital chart.
Data analysis
Descriptive statistics were used to characterise the cohort and
univariate analyses were performed. Although participants were
asked to rate the impact of diabetes on routine activities, the mild,
moderate and severe categories were collapsed into one category
because very few participants reportedmoderate or severe impact.
Participants who did not report having diabetes but had a
diagnosis of diabetes in the chart were categorised as having
diabetes without impact on their routine activities.
Linear mixed modelling was used to examine the pattern of
recovery for WOMAC pain and function scores over the four time
points because non-linear equations, as opposed to a linear
equation, provided the best ﬁt for predicting pain and function
scores over the 6 months. Linear mixed modeling also allowed
available data to be used at each time period, unlike repeated
measures analysis, which requires complete datasets over all time
periods.19 The linear mixed models included parameters that
estimated either pain or function for TKA before surgery, and the
rate of change during the recovery. The square of time was also
included as an estimate of change in the recovery rate because of
the quadratic relationship over time forWOMAC pain and function
scores. The model had two levels, which consisted of one level for
the within-individual change over time and the other for between-
individual differences in change over time.
In the multivariate linear mixed models, variables were
selected using both forward selection and backward elimination
procedures. Forward selection started with a simple linear mixed
model, then considered all of the reasonable one-step-more-
complicated models and chose the one with the smallest p-value
for the new parameter. This continued until no additional variables
had a signiﬁcant p-value. Backward elimination started with a
complicated model, including all those variables with a p-
value < 0.2 in the univariate linear mixed model, and removed
the variable with the largest p-value at each step, as long as that p-
value was larger than 0.05. In the ﬁnal multivariable linear mixed
models, all variables with a p-value of less than 0.05 or clinically
important variables with a p-value close to 0.05 were kept in the
models. Within this model, time squared, diabetes status, baselineTable 1
Baseline characteristics of participants by diabetes status.
Characteristics Total
(n=405)
Age (yr), mean (SD) 68 (10)
Gender (female), n (%) 249 (62)
Marrried or de facto, n (%) 260 (64)
MOS score (0 to 100), mean (SD) 79 (22)
Completed high school, n (%) 316 (78)
Body mass index (kg/m2), mean (SD) 32.1 (6.5)
Comorbidities (n), mean (SD) 5.7 (2.2)
Cardiac disease, n (%) 90 (22)
Depression (CES-D  16), n (%) 85 (21)
Kidney disease, n (%) 16 (4)
Visual impairment, n (%) 139 (34)
Other weight-bearing joint involvement a, n (%) 346 (86)
In-hospital complications, n (%) 55 (14)
joint-related 11 (3)
medical-related 40 (10)
joint and medical-related 4 (1)
Acute care length of stay (d), mean (SD) 6.3 (3.0)
Discharged directly home from acute care, n (%) 231 (60)
MOS=Medical Outcomes Study Social Support Survey, CES-D=Centre for Epidemiologi
a Contralateral (hip, knee and/or ankle) and/or ipsilateral weight-bearing (hip and/oWOMACpain and function scores, depression, kidney disease,MOS
social support score, HUI3 score, other weight-bearing joint
involvement, age and gender were treated as ﬁxed effects where
the ﬁxed effects describe the mean change in the population.
A p-value was considered to be statistically signiﬁcant if less
than 0.05 for main level factors and if less than 0.10 for interaction
terms. Age, gender, and other weight-bearing joint involvement
variables were kept in all the multivariable models regardless of
their statistical signiﬁcance. All statistical testing was performed
with two-tailed tests.
Results
Of the 500 people who were scheduled for TKA, 405 (81%)
participated in the study. The characteristics of participants are
presented in Table 1. The mean age of the cohort was 68 years
(SD 10) and 249 (62%) were female. In total, 380 (94%) participants
had two or more comorbid conditions, among which 60 (15%)
had diabetes. Hypertension was the most prevalent comorbidity
(n = 216, 53%) followed by low back pain (n = 155, 38%).
Contralateral joint involvement affected 117 (18%) at the hip
and 298 (25%) at the knee. Postoperative in-hospital complications
occurred in 18% of participants with diabetes and 13% of
participants without diabetes. The most common types of
complications were postoperative delirium (n = 17, 4%), joint or
wound infection (n = 15, 4%) and urinary tract infection (n = 14,
3%). The mean length of stay in acute care was 6 days (SD 3).
The diagnosis of diabetes had 97% exact agreement between
chart review and participant reports. Of the 60 participants with
diabetes,19(32%)participants reported thatdiabetes impactedtheir
ability to perform daily routine activities. The number of partici-
pants with self-reported diabetes remained relatively constant over
the 6 months. Eighty percent of participants with diabetes had
hospital admission glucose levels above 6.0 mmol/L and 65% were
taking either oral hypoglycaemics or insulin for their diabetes.
No signiﬁcant differences were seen between the diabetic and
non-diabetic participants for age (p = 0.42), gender (p = 0.26), or
chronic comorbidities such as heart disease, kidney disease and
visual impairment, as presented in Table 1. Participants with
diabetes that impacted on routine activities had amean bodymass
index (BMI) of 35.8 kg/m2 (SD 7.1), which was higher than
participants with diabetes that did not impact on routine activities
(mean 33.7 kg/m2, SD 6.6) and participants without diabetes
(mean 31.7 kg/m2, SD 6.3).
Pre-operative WOMAC pain and function scores were similar
among the three groups (Figure 1). At 1, 3 and 6 months afterNo diabetes
(n=345)
Diabetes without
impact on routine
activities (n=41)
Diabetes with
impact on routine
activities (n=19)
68 (10) 68 (9) 65 (12)
216 (63) 19 (46) 14 (74)
220 (64) 29 (71) 11 (58)
78 (23) 83 (22) 78 (18)
71 (79) 30 (73) 15 (79)
31.7 (6.3) 33.7 (6.6) 35.8 (7.1)
5.5 (2.2) 6.7 (2.0) 7.3 (2.2)
76 (22) 10 (24) 3 (16)
72 (21) 4 (10) 3 (16)
12 (4) 2 (5) 2 (11)
120 (35) 10 (24) 9 (47)
295 (86) 36 (88) 15 (79)
44 (13) 8 (20) 3 (16)
7 (2) 2 (5) 2 (11)
33 (10) 6 (15) 1 (5)
4 (1) 0 (0) 0 (0)
6.2 (2.6) 7.3 (5.6) 6.0 (2.3)
203 (61) 21 (55) 7 (44)
c Studies Depression Scale.
r ankle) joint(s).
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Figure 1. Unadjusted mean Westarn Ontario and McMaster Osteoarthritis Index
(WOMAC) scores and overall Health Utility Index 3 (HUI3) scores for total knee
arthroplasty within the preoperativemonth (pre-op) and at the three postoperative
measurement times. Error bars indicate standard deviations. (a) WOMAC pain
scores with lower scores representing less pain. (b) WOMAC function scores with
lower scores indicating greater function. (c) Overall HUI3 scores. Negative scores
assigned to health states are considered to be worse than dead, a score of zero
reﬂects the health state ‘dead’ and 1.0 indicates ‘perfect health’.
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activities had greater pain scores than the other two groups. These
differences were of a magnitude that people typically consider to
be somewhat different.22 A similar pattern was also seen with the
WOMAC function scores. Participants with diabetes that impacted
on routine activities had poorer function than the other two groups
(Figure 1). Although no statistically signiﬁcant differences were
seen among the groups at 1 month, function scores were
signiﬁcantly poorer for participants in the diabetes with impactgroup than the other two groups at 3 (p < 0.01) and 6 months
(p < 0.05).
At baseline, the overall HUI3 scores for the three groups differed
by more than 0.03, which was the threshold that was adopted as
being clinically meaningful. Participants who reported diabetes
that impacted on routine activities had a mean score of 0.38 (SD
0.32), while those with diabetes without impact scored 0.47 (SD
0.21) and thosewith no diabetes scored 0.50 (SD 0.25), as shown in
Figure 1. These health-related quality of life scores improved over
the 6 months after surgery in all three groups. While participants
with diabetes that impacted on routine activities reported lower
overall health at all four time points, differences of 0.03 or greater
were not seen between the other two groups over the three follow-
up time points. The numerical data used to generate Figure 1 are
available in Table 2 in the eAddenda.
The unadjusted parameter estimates in Table 3 show that
participants with diabetes that impacted on routine activities
reported less reduction in pain over the 6 months after surgery
than the other two groups. Poorer health status, less perceived
social support, living alone, kidney disease, and depression at
baseline predicted less reduction in pain over the 6 months after
surgery. Several baseline factors (health status, perceived social
support, living alone, kidney disease and depression) were also
signiﬁcantly predictive of functional recovery over the 6 months.
When adjusting for other factors such as age, gender and other
weight-bearing joint involvement in the multivariable model
(Table 4), variables associated with less reduction in pain included
diabetes with an impact on routine activities, depression and less
social support, and kidney disease. Similarly, variables associated
with less functional improvement included diabetes with an
impact on routine activities, poorer health status, kidney disease
and less social support. Over the course of recovery, pain scores
were an average of 8.3 units higher, which indicated greater pain in
the group with diabetes that impacted on activities compared to
the group without diabetes. Function scores were an average of
5.4 units higher, indicating lower function in the diabetes with
impact group than the group without diabetes.
Discussion
The results of this longitudinal study suggest that recovery over
6 months after TKA was slower in participants who reported
diabetes that impacts on routine activities than either those
without diabetes or those with diabetes that does not impact on
routine activities. Although there were no differences in pain or
function before surgery among the three groups, different patterns
of recovery were seen, depending upon the perception of impact of
diabetes on functional activities. Participants with diabetes that
impacted on their activities had less resolution of pain and less
functional improvement than the other two groups.
Preoperative joint pain and function were similar for the three
groups, yet clinical differences for overall health (HUI3 scores)
were seen among the three groups over the four time points. The
lower health status in this study cohort could be due, in part, to
greater pain and ambulatory deﬁcits, which are attributes that are
heavily weighted in the overall HUI3 score. Over the course of the
present study, the three groups had considerably lower health
status, as seen with lower HUI3 scores when compared to the
general community-dwelling population with diabetes without
comorbidities (0.88), those with one comorbidity (0.77 to 0.79),
and those with two comorbidities (0.64 to 0.66).37
To our knowledge, this is the ﬁrst study to show that the
severity of diabetes, as indicated by its perceived impact on
function, was predictive of recovery after TKA. While most studies
have deﬁned diabetes as a dichotomous variable or in terms of
glycemic control, asking participants to report the impact of a
condition on routine activities provides insight into the functional
impact of the condition. This has direct implications for
physiotherapists in their assessment of people undergoing TKA.
Table 3
Unadjusted parameter estimates for the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores.a
Category Referent Pain Function
Factors Coeff (95% CI) p-value Coeff (95% CI) p-value
Sociodemographic
Age (yr) 0.03 (0.12 to 0.06) 0.51 0.04 (0.04 to 0.13) 0.32
Gender
female male 0.15 (2.11 to 1.80) 0.88 1.07 (2.91 to 0.77) 0.25
High school education
completed not 0.98 (1.30 to 3.26) 0.40 2.01 (0.13 to 4.14) 0.065
MOS score (0 to 100) 0.06 (0.10 to 0.02) 0.01 0.04 (0.08 to 0.002) 0.04
Living status
alone with others 2.82 (0.64 to 5.01) 0.01 3.50 (1.45 to 5.54) 0.001
Health
HUI3 (–0.36 to 1.0) 4.97 (9.23 to 0.72) 0.02 6.37 (10.50 to 2.25) 0.003
BMI
 30 kg/m2 < 30 kg/m2 0.68 (2.60 to 1.23) 0.48 0.44 (1.36 to 2.24) 0.63
Medical
Diabetes status
without impact no diabetes 0.08 (3.12 to 2.97) 0.96 0.10 (2.99 to 2.79) 0.95
with impact 8.48 (4.22 to 12.75) <0.001 5.77 (1.71 to 9.84) 0.006
High blood pressure 1.46 (3.39 to 0.47) 0.14 0.49 (2.30 to 1.33) 0.60
Cardiac disease 1.34 (2.09 to 4.77) 0.44 1.05 (1.44 to 3.54) 0.41
Circulatory problems 1.31 (1.32 to 3.94) 0.33 0.35 (3.57 to 2.88) 0.83
Kidney disease 4.69 (0.01 to 9.39) 0.05 5.34 (0.95 to 9.73) 0.02
CES-D
 16 < 16 3.39 (0.79 to 6.00) 0.01 2.23 (0.26 to 4.72) 0.08
Other joint involvement b not 2.24 (0.87 to 5.35) 0.16 0.04 (2.58 to 2.51) 0.98
CES-D=Centre for Epidemiologic Studies Depression Scale, HUI3=Health Utilities Index Mark 3, MOS=Medical Outcomes Study Social Support Survey.
a Intercept, time, time-square, baseline pain or function, baseline x time were also included in the models. Referent reported for dichotomous variables.
b Contralateral (hip, knee and/or ankle) and/or ipsilateral weightbearing (hip and/or ankle) joint(s).
Research 221Although the severity of diabetes has been evaluated in terms of
glycemic control in people with total joint arthroplasty,5 it was
found that admission fasting blood glucose levels were not
signiﬁcant in explaining the 6-month trajectories for pain and
function. Glycemic control was predictive of complications,
mortality, increased length of stay, and higher hospital charges
after total joint arthroplasty in a large patient sample.5 Others have
not evaluated the severity of the diabetes, but rather evaluated
chronic conditions as a simple count to capture the burden of
illness or treated diabetes as a dichotomous factor. Many of these
approaches do not take into account the severity or functional
impact of the disease when evaluating outcomes after joint
arthroplasty.Table 4
Model parameter estimates for the Western Ontario and McMaster Universities Osteoa
Factors a Pain
Coeff (95% CI)
Intercept 25.9 (16.1 to 35.7)
Time 8.56 (10.10 to 7.02)
Time-square 1.41 (1.23 to 1.59)
Diabetes
without impact 0.11 (2.91 to 3.12)
with impact 8.28 (4.05 to 12.51)
CES-D  16 3.24 (0.57 to 5.90)
Kidney disease 4.63 (0.02 to 9.24)
MOS 0.05 (0.09 to 0.01)
HUI3
Gender (female) 0.63 (2.55 to 1.28)
Age (yrs) 0.03 (0.12 to 0.07)
Other joint involvement b 0.96 (1.73 to 3.64)
Baseline pain c 0.68 (0.62 to 0.75)
Baseline function c
BaselineTime 0.10 (0.12 to 0.07)
Variance Estimates
Within-patient residual 165 (151 to 180)
Intercept 22.4 (11.9 to 42.3)
Time 4.1 (2.8 to 6.2)
CES-D=Centre for Epidemiologic Studies Depression Scale, HUI3=Health Utilities Inde
a Random effect was the intercept that indicates the average score at baseline and t
b Contralateral (hip=knee and/or ankle) and/or ipsilateral weight-bearing (hip and/o
c Baseline WOMAC scores.While no single condition is completely responsible for the
outcome after total joint arthroplasty, other conditions associated
with diabetes also had signiﬁcant deleterious effects on recovery,
such as depression and kidney disease. Depression is not surprising
because evidence has recognised that psychosocial symptoms such
as depression are associated with osteoarthritis38,39 and less pain
relief and functional gains after TKA.40,41 Chronic kidney disease is
a serious complication of diabetes,42,43 yet kidney disease had an
independent effect on recovery after TKA. The interaction between
diabetes and kidney disease was not signiﬁcant. This is most likely
because this cohort had a small proportion of kidney disease. The
effect of kidney disease on recovery after TKA has not been
explicitly examined in the literature and warrants furtherrthritis Index (WOMAC) pain and function scores.
Function
p-value Coeff (95% CI) p-value
< 0.001 19.9 (10.6 to 29.2) < 0.001
< 0.001 6.90 (8.20 to 5.60) < 0.001
< 0.001 1.12 (0.96 to 1.28) < 0.001
0.94 0.79 (3.70 to 2.11) 0.59
< 0.001 5.42 (1.39 to 9.46) < 0.01
0.02
0.049 4.39 (0.03 to 8.75) 0.048
0.04 0.04 (0.08 to 0.001) 0.049
5.41 (9.55 to 1.26) 0.01
0.58 1.38 (3.20 to 0.45) 0.14
0.58 0.04 (0.05 to 0.12) 0.39
0.48 0.60 (1.97 to 3.18) 0.65
< 0.001
0.69 (0.62 to 0.75) < 0.001
< 0.001 0.08 (0.10 to 0.07) < 0.001
< 0.001 130 (119 to 142) < 0.001
0.002 26.8 (16.9 to 42.7) < 0.001
< 0.001 3.1 (2.1 to 4.7) < 0.001
x Mark 3, MOS=Medical Outcomes Study Social Support Survey.
ime. All other factors were treated as ﬁxed effects.
r ankle) joint(s).
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chronic kidney disease, such as diabetes or hypertension, also
receiving TKA.
A strength of our study was the method used to deﬁne the
functional impact of diabetes. Diabetes was examined in the
context of functional difﬁculty in performing routine activities,
which was congruent with the measured outcomes, joint-speciﬁc
pain and function. Rather than evaluating a single point in time
after surgery, the trajectory of recovery was examined, when the
greatest gains are reported to occur when recovering from total
joint arthroplasty. Lastly, the external validity of the ﬁndings were
based on a community-based cohort within a universal healthcare
system rather than recruitment from a single centre.
Some limitations also warrant recognition, in particular,
deﬁning diabetes status in this cohort. Diabetes was determined
by self-report, chart review or both. In particular, 12 (20%)
participants with diabetes documented in the chart did not report
having diabetes. The preoperative assessment was performed
during the month prior to surgery and it is possible that some of
these participants were newly diagnosed. Nevertheless, a small
degree of misclassiﬁcation of diabetes is a limitation that needs to
be recognised. There was a relatively small subgroup of
participants who reported that diabetes impacted on their routine
activities, yet they had a large and statistically signiﬁcant effect in
the univariate and multivariable models for WOMAC pain and
function scores. Although this was a community-based study that
included three hospitals and 29 surgeons, the small number of
participants with diabetes may be due, in part, to only those who
were medically ﬁt being recommended for this elective surgery.
The ﬁndings from this study indicate that diabetes, along with
other associated comorbid conditions, is complex and burden-
some. Knowing which conditions account for the amount of
impairment during recovery will provide direction to institute
treatment priorities, both within the hospital and community
settings. Physiotherapy after total joint arthroplasty is effective
during the post-discharge recovery period44,45 and providing
targeted treatment for a subset of people who are at risk of slower
recovery may maximise their rehabilitation potential. To identify
that subset, physiotherapists can simply ask during preoperative
screening whether diabetes impacts on routine activities. People
who are identiﬁed in this way can be monitored more closely over
the 6 months following surgery.What is already known on this topic: People undergoing a
total knee arthroplastywho also have diabetes are at increased
risk of surgical complications, systemic complications, pro-
longed hospitalisation and mortality.
What this studyadds: Diabetes is also associatedwith slower
resolution of pain and recovery of function after total knee
arthroplasty, but only if the diabetes is severe enough that the
person perceives preoperatively that it impacts on the comple-
tion of routine daily activities. Physiotherapists can therefore
prospectively identify peoplewho are at risk of slower recovery
after total knee arthroplasty simply by asking those with
diabetes if their diabetes impacts on their daily activities.eAddenda: Table 2 can be found online at doi:10.1016/j.jphys.
2014.09.006
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